PView Strongroom AI and EasyDose Merger 090322

Listen to this episode of the Pharmacy View Podcast, where host Scott Carpenter, EVBC talks with Noel Fosbery, Director, EasyDose Dispensing Solutions and Max Mito, Co-Founder / CEO at StrongRoom AI. While EasyDose is a program for pharmacies providing Opioid Replacement Pharmacotherapy Solutions, StrongRoom AI is an Artificial Intelligence-driven controlled drugs management platform aimed at reducing adverse drug events within the Pharmacy, Hospital and Aged Care Facility settings. And in this episode, they talk about the collaboration of the two. Noel is a WA Pharmacist and Proprietor at Advantage Pharmacy (Falcon, High Wycombe and Morley) and in 2016, his service was recognised as WA & Australian Pharmacist of the Year! With his motto of ‘Do it right, do it once’, Noel, who is also a keen early adopter of technology, looks forward to merging his experience with the technology that Max and his team at StrongRoom AI bring. Having started a decade ago, EasyDose has come a long way, however along that journey Noel and his partners realised they had limited resources that in the long run, could affect customers and limit technological progression so after significant research have decided to now partner with StrongRoom AI. The key to successfully accelerating the product roadmap and building a more robust system, Max says, is collaboration. While StrongRoom AI has expertise on the technological front, Max adds, Noel and his team come with years and years of actual experience in the field. Max believes that in the future their collaboration would help them all: - Keep building new and better products - Keep adding value for the customers Noel also stresses the importance of collaboration and is excited by the possibilities because he believes StrongRoom AI’s team comes with a fresh outlook to innovation that many Pharmacists don’t even think as being possible and are also open to providing information and advice from those who work on the ground. He furthers that the future of the Pharmaceutical industry depends on software as evidenced over the last two years.